SEC Form 4 · accession 0001209191-15-003360
JUNIPER PHARMACEUTICALS INC · JNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bridget A Martell
Officer — Chief Medical Officer
Period of report
Jan 6, 2015
Accepted (ET)
Jan 9, 2015 · 1:51 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000821995
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $5.63 | Jan 6, 2015 | A | 60,000 | A | Jan 6, 2016 | Jan 6, 2022 | $.01 par value of common stock | 60,000 | 60,000 | D |
Explanation of responses
- F1The option will become exercisable in 25% increments of the shares on each annual anniversary of the date of the grant.